US20100244331A1 - Method for Production of Nanofibres - Google Patents

Method for Production of Nanofibres Download PDF

Info

Publication number
US20100244331A1
US20100244331A1 US12/738,164 US73816408A US2010244331A1 US 20100244331 A1 US20100244331 A1 US 20100244331A1 US 73816408 A US73816408 A US 73816408A US 2010244331 A1 US2010244331 A1 US 2010244331A1
Authority
US
United States
Prior art keywords
spinning
nanofibres
chitosan
biopolymer
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/738,164
Other languages
English (en)
Inventor
Jana Svobodova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elmarco sro
Original Assignee
Elmarco sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elmarco sro filed Critical Elmarco sro
Assigned to ELMARCO S.R.O. reassignment ELMARCO S.R.O. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SVOBODOVA, JANA
Publication of US20100244331A1 publication Critical patent/US20100244331A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F4/00—Monocomponent artificial filaments or the like of proteins; Manufacture thereof
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Definitions

  • the invention relates to method for production of nanofibres through electrostatic spinning of polymer matrices prepared upon biopolymers of chitosan or collagen.
  • the invention relates to fabric comprising at least one layer of nanofibres produced through electrostatic spinning of biopolymer of chitosan or collagen.
  • Biopolymers feature a number of unique properties thanks to which they are suitable for application in medicine, first of all thanks to its biocompatibility and nontoxicity. Important is their application e.g. for production of bandages and plasters, but also for implants and antiadhesive mats, where they expressively decrease the risk of occurrence of postoperative adhesions between the tissues, further in dental medicine, cosmetics and surgery plastic for filling of dermatic or bone defects. Some of the biopolymers are biodegradable, that means decomposable e.g. by action of enzymes.
  • the nanofibrous materials of biopolymers are of a high porosity as well as of a specific surface, are penetrable for oxygen but not penetrable for microbes, at the same time they preserve all above mentioned properties of the used biopolymers.
  • Biopolymer nanofibres are suitable e.g. for healing of burns, when they ensure an optimum humidity at healing and simultaneous removal of exudate from the wound, further for the bandage materials, plasters, etc.
  • chitosan is the polycationic polysaccharide composed of ⁇ -(1 ⁇ 4) 2-acetamido-2-deoxy-D-glucopyranosic and 2-amino-2-deoxy-D-glucopyranosic units.
  • chitin is the polycationic polysaccharide composed of ⁇ -(1 ⁇ 4) 2-acetamido-2-deoxy-D-glucopyranosic and 2-amino-2-deoxy-D-glucopyranosic units.
  • alkaline deacetylation the source of which are the shellfish, e.g. the shells, mussels, crabs and crayfish, it is also contained in tectrices of insect and also in mushrooms.
  • Chitosan is biodecomposable, biocompatible, thanks to positive charge at physiological pH it is bioadhesive, which is a great advantage in healing of wounds, it has hemostatic effects, thus stops bleeding, it has also antibacterial effects.
  • it is contained in most of the reduction diets.
  • it is directly designated for application in medicine, e.g. for the already mentioned plasters and bandages, but also for the antiadhesive mats into the body or in dental medicine for filling to stop bleeding. It is also used in biotechnologies for purification of waste waters or liquids, e.g. beer, wine or milk.
  • chitosan Most types of chitosan are insoluble in water, but soluble in organic acids with pH of solution lower than 5. Most frequently are as solvent used the acetic acid, lactic acid, malic acid, oxalic acid, etc.
  • chitosan At present great number of scientific laboratories and institutions deal with chitosan.
  • the method of electrostatic spinning is used.
  • the nanofibres from chitosan are produced by means of spinning devices with needle or jet spinning electrode.
  • WO2007093805A1 discloses production of composite fibres from chitosan and alginate, where the maximum content of chitosan reaches 80%, whereas the chitosan fibres coat the surface of alginate fibres. Due to the diameter of fibres, which is 50 ⁇ m, these fibres are not nanofibres.
  • WO2006133118A1 generally deals with biopolymers in a nanofibrous form, where alternate the nanofibrous layers of polymer soluble in water and insoluble in water. Diameters of produced nanofibres are in the range of 1 to 25000 nm, which is not the nano dimension any more.
  • KR100652469B deals with antibacterial nanofibres, which are made of chitosan in mixture with polyethylene terephthalate. As a solvent the trifluorethanol, hexafluoroisopropanol or trifluoroacetic acid is used.
  • Another Korean patent deals with production of nanofibres of chitin or chitosan upon usage of jets as the spinning electrodes.
  • solvents the N-methylmorpholineoxid, hexafuoro-2-propanol or hexafluoroacetone hydrate and formic acid are used.
  • WO2006048829 patent deals with new derivates of chitin in a nanofibrous form for application in medicine, mainly for application to protect skin and as hypodermic fillings.
  • the used biopolymers are oxychitin, chitin of glycolate, chitin of hyaluronate. Also here is for production of nanofibres used the needle spinning electrode.
  • WO03042251A1 patent discloses production of composites containing chitosan in the form of nanodimensional fibres for the purpose of increasing the activity and solubility mostly for usage in cosmetic. Nevertheless the length of produced nanofibres is considerably limited and it varies in the range of 5 to 200 nm, while their diameter is in the range of 5 to 30 nm, which corresponds rather to the size of nanoparticles than the nanofibres.
  • Another patent KR1020050048360AA deals with production of nanofibrous nonwoven fabric for tissue engineering, where for production of nanofibres the natural polymer from the group of chitosan, collagen, alginic acid and synthetic polymer is used, e.g. homopolymer of lactic acid, copolymer of lactic acid and of gluconic acid, homopolymer of gluconic acid and their mixtures, while the ratio of natural and synthetic polymer is 4:1 to 1:4.
  • N.Bhattarai Biomaterials, vol. 26, Iss. 31, 2005, p. 6176-6184 deals with production of nanofibres from the mixture of chitosan: PEO in maximum ratio 90:10, where as solvent non-ionic tenside Triton X-100TM is used.
  • solvent non-ionic tenside Triton X-100TM is used as a spinning electrode.
  • the syringe is used and the applied voltage is 20 to 25 kV and distance of electrodes is 17 to 20 cm.
  • X. Geng et. al. deals with spinning of chitosan in concentrated acetic acid (Biomaterials, Vol. 26, 2005, p. 5427-5432). They use 7% chitosan in 90% acetic acid at applied voltage of 4 kV/cm. At higher voltage nanofibres defects occur, when lower concentration of acid is used the problems with too high surface tension of polymer solution arise. As a spinning electrode the nozzle is used and the achieved diameter of nanofibres is 130 nm.
  • Another possible method for production of nanofibres from chitosan is spinning of chitosan solution with addition of polyvinyl alcohol, like Lei Li and his group (Carbohydrate Polymers, Vol. 62, 2006, p. 142-158) deals with.
  • the original solution is composed of mixture PVA/chitosan in ratio 83/17 (w/w) in 2% acetic acid, while the achieved diameter of nanofibres is 20 to 100 nm. Then PVA is removed from nanofibres through leaching in NaOH.
  • collagen Another in medicine mostly used biopolymers is collagen which is applicable especially at healing of burns, as implants, for artificial dermal fillings, artificial skin, artificial cartilages, vertebras, etc.
  • Collagen is contained e.g. in skin, vascular walls, cartilages, ligament.
  • In medicine are used primarily the types I, II and III.
  • Collagen is formed of three polypeptides creating the ⁇ -helix with regularly repeating amino acids Gly-Pro-Hyp. It is insoluble in water and soluble in a few of solvents, out of which the mostly used is hexafluoroisopropanol. Through chemical or thermal degradation the gelatine is obtained.
  • CN1944724 is a patent that deals with production of composites of chitosan and collagen.
  • a solvent the hexafluoroisopropanol and trifluoracetic acid or their mixture are used.
  • One of publications which deals with spinning of collagen of type I is article of J. A. Matthews (Biomacromolecules, Vol. 3, 2002, p. 232-238), where as a solvent hexafluoroisopropanol is applied.
  • WO2006068421A1 discloses production of nanofibrres which are formed of polyhydroxyalkanoate, collagen or gelatine.
  • the spinning electrode applied for production of these nanofibres is nozzle or needle, and diameter of nanofibres varies in the range of 50 to 2000 nm.
  • the goal of this invention is to suggest the method for production of nanofibres of biopolymers through electrostatic spinning, which would remedy the disadvantages of the background art.
  • the goal of the invention has been achieved by production method of nanofibres through electrostatic spinning of polymer matrices prepared upon on biopolymers of chitosan or collagen according to the invention, whose principle consists in that, the biopolymer is before spinning dissolved as clean or in mixture with auxiliary non-toxic polymer in solvent system, which contains an organic or inorganic acid, selected from the group of acetic acid in concentration from 30% to 90% of weight, lactic acid, malic acid, trihydrogen-phosphoric acid and their mixtures, and this solution is brought into electrostatic field between the spinning electrode and collecting electrode, while the produced biopolymer nanofibres comprise more than 90% of weight of biopolymer in dry mass.
  • auxiliary non-toxic polymer in solvent system which contains an organic or inorganic acid, selected from the group of acetic acid in concentration from 30% to 90% of weight, lactic acid, malic acid, trihydrogen-phosphoric acid and their mixtures
  • biopolymer nanofibres comprisen more than 95% of biopolymer in the dry mass.
  • Constant quality results at spinning are achieved if the solvent system comprises the acetic acid.
  • chitosan of molecular weight lower than 150 kDa is before spinning dissolved in acetic acid of concentration higher than 50% wt. together with auxiliary nontoxic polymer PEO.
  • the fibres of chitosan may be produced also without addition of PEO, as it is shown in the claim 5 .
  • collagen is before spinning dissolved in the solvent system comprising the diluted acetic acid and the auxiliary polymer PEO or PVA soluble in water having concentration of 1 to 3%.
  • the constant good spinning results are achieved, if the biopolymer solution in electric electrostatic field for spinning is positioned on surface of the active zone of spinning mean of the spinning electrode.
  • biopolymer solution is delivered to electrostatic field for spinning through surface of the spinning electrode.
  • the spinning electrode is with advantage formed of a rotating spinning electrode of an oblong shape, which by section of its perimeter extends into the biopolymer solution.
  • such spinning electrode comprises a couple of faces made of electrically non-conductive material, between which are positioned the spinning members created of wire, which are equally distributed around perimeter, parallel with axis of rotation and mutually electrically conductive connected.
  • biopolymer solution in electrostatic field for spinning is situated on surface of the active spinning zone of the spinning means.
  • Active spinning zone of the cord during spinning has a stable position towards the collecting electrode and biopolymer solution to the active spinning zone of the cord is delivered by applying or by a motion of the cord in direction of its length.
  • Chitosan is dissolved solitary or in mixture with auxiliary nontoxic polymer, especially the one soluble in water, which is in ideal case biocompatible and biodegradable.
  • the example is polyvinylalcohol, polyethylene oxide or polyvinylpyrrolidone.
  • Chitosan is used in the concentration of 5-25 wt. % in dependence on the solvent system, which is formed of organic or inorganic acid, especially the acetic acid, while concentration of acetic acid is higher than 30% and lower than 90%. Further the lactic acid, malic acid and trihydrogen phosphoric acid or their mixtures may be used.
  • the ratio of chitosan and of the auxiliary polymer is higher than 90:10 to the dry mass of nanofibres.
  • reticulate agents e.g. dialdehydes, dicarboxylic acids, genipin, trisodium citrate.
  • the process depends on molecular weight of chitosan, grade of deacetylation, concentration, or viscosity, surface tension, temperature and humidity of surroundings and parameters of technology, like rotation and type of electrode, distance between electrodes and applied voltage.
  • the device for electrostatic spinning of polymer solutions comprising the spinning electrode, which comprises the rotatably mounted spinning means extending by a portion of its perimeter into the biopolymer solution being present in the reservoir.
  • the rotatable spinning means due to its rotation carries out the biopolymer solution into electrostatic field of a high intensity, which is created by difference of potentials between the spinning electrode and against it arranged collecting electrode, while the section of surface of the rotating spinning means positioned against the collecting electrode represents the active spinning zone of the spinning means.
  • the biopolymer solution is to be found in electrostatic field on surface of the active spinning zone of the spinning means of the spinning electrode.
  • the rotatable spinning means may be performed for example according to the CZ patent 294274 or according to CZ PV 2006-545 or CZ PV 2007-485.
  • Collagen of the type I underwent spinning from its solution in diluted acetic acid, so that halogen solvents, which may cause problems in medicine applications, were not used.
  • the residua of acetic acid may be removed by a short term warming of the nanofibrous material.
  • the nanofibres of collagen may be reticulated by the same means as chitosan. Achieved weight ratio of colagenu and auxiliary polymer is higher than 90:10.
  • the applied voltage of 6 to 7 kV/cm.
  • nanofibres of chitosan may have diameter of 10 to 250 nm, the nanofibres of collagen 10 to 200 nm. In all cases a long term continual spinning process has been achieved.
  • Chitosan of a low molecular weight (lower than 150 kDa, with viscosity 0.5% of solution in 0.5% solution of acetic acid between 5-30 mpa ⁇ s), of the grade of deacetylation at min. 75% before spinning is dissolved in diluted acetic acid with concentration higher than 50% and it is left to be mixed for a period of 12 hours at minimum. After stabilising it is mixed with mixture of auxiliary in water soluble polymer like the PEO of molecular weight 300000-400000 and concentration 1-3% at temperature to 35° C., humidity to 60%, and this solution is delivered into electrostatic field between the spinning electrode and collecting electrode.
  • auxiliary in water soluble polymer like the PEO of molecular weight 300000-400000 and concentration 1-3% at temperature to 35° C., humidity to 60%
  • collagen Before spinning, collagen is dissolved in solvent system comprising the acetic acid 87, 5% of weight, the auxiliary polymer (PEO or PVA) soluble in water (concentration of 1-3%) at temperature to 35° C., humidity to 60% and this solution is brought into electrostatic field between the spinning electrode and collecting electrode.
  • solvent system comprising the acetic acid 87, 5% of weight, the auxiliary polymer (PEO or PVA) soluble in water (concentration of 1-3%) at temperature to 35° C., humidity to 60% and this solution is brought into electrostatic field between the spinning electrode and collecting electrode.
  • the chitosan as well as collagen nanofibres provide a large possibilities of application, first of all in medicine, and thanks to possibility of nearly any surface density of nanofibres they may be applicable also as substrateless materials, antiadhesive mats, plasters, implants and fillings of undesired bone or dermal defects. Chitosan thanks to hemostatic effects may be used at operation or in dental medicine to stop bleeding along reduction of economic costs and simultaneous speeding of wound healing.
  • Colagen nanofibres will surely find their application solitary as replacement of damaged ligaments, tendons and cartilages or at injury of backbone, e.g. the intervertebral plate, or also for coating of implants, which reduces the negative immunity response of organism after introduction of a foreign element into the body.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Textile Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mechanical Engineering (AREA)
  • Artificial Filaments (AREA)
  • Materials For Medical Uses (AREA)
  • Nonwoven Fabrics (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
US12/738,164 2007-10-15 2008-10-15 Method for Production of Nanofibres Abandoned US20100244331A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ20070716A CZ2007716A3 (cs) 2007-10-15 2007-10-15 Zpusob výroby nanovláken
CZPV2007-716 2007-10-15
PCT/CZ2008/000124 WO2009049565A2 (en) 2007-10-15 2008-10-15 Method for production of nanofibres

Publications (1)

Publication Number Publication Date
US20100244331A1 true US20100244331A1 (en) 2010-09-30

Family

ID=40567834

Family Applications (1)

Application Number Title Priority Date Filing Date
US12/738,164 Abandoned US20100244331A1 (en) 2007-10-15 2008-10-15 Method for Production of Nanofibres

Country Status (12)

Country Link
US (1) US20100244331A1 (cs)
JP (1) JP2011500980A (cs)
CN (1) CN101903568A (cs)
AU (1) AU2008314287A1 (cs)
BR (1) BRPI0818424A2 (cs)
CA (1) CA2702368A1 (cs)
CZ (1) CZ2007716A3 (cs)
IL (1) IL205093A0 (cs)
MX (1) MX2010004085A (cs)
PH (1) PH12010500803A1 (cs)
TW (1) TW200925342A (cs)
WO (1) WO2009049565A2 (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113445155A (zh) * 2021-07-22 2021-09-28 东北师范大学 一种壳聚糖基纳米纤维及其制备方法

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5807329B2 (ja) * 2009-12-25 2015-11-10 東洋紡株式会社 コラーゲン繊維の集合体およびその製造方法
EP2394670A1 (en) * 2010-06-04 2011-12-14 Université de Liège Chitosan-based biomimetic scaffolds and methods for preparing the same
JP5453690B2 (ja) * 2010-06-18 2014-03-26 国立大学法人東京工業大学 コラーゲン・キトサン複合繊維状多孔体及びその製造方法
RU2468129C2 (ru) * 2010-12-30 2012-11-27 Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный университет им. Н.Г. Чернышевского" Биополимерное волокно, состав формовочного раствора для его получения, способ приготовления формовочного раствора, полотно биомедицинского назначения, способ его модификации, биологическая повязка и способ лечения ран
RU2487701C2 (ru) * 2011-07-26 2013-07-20 Общество с ограниченной ответственностью "Инмед" Раствор для получения материала на основе хитозана, способ получения гемостатического материала из этого раствора (варианты) и медицинское изделие с использованием волокон на основе хитозана
CN102877147A (zh) * 2012-09-24 2013-01-16 四川大学 胶原蛋白水溶液静电纺丝制备纳米纤维的方法
CZ304564B6 (cs) * 2013-02-12 2014-07-09 Univerzita Pardubice Způsob přípravy vláken z chitin/chitosan-glukanového komplexu, vlákna a kryt rány
GB2514597A (en) 2013-05-30 2014-12-03 Medtrade Products Ltd Degradable haemostat composition
GB2514592A (en) * 2013-05-30 2014-12-03 Medtrade Products Ltd Degradable haemostat composition
CN104007040B (zh) * 2014-06-05 2016-05-18 广州纺织服装研究院有限公司 一种检测覆盖型胶原改性纤维织物中胶原含量的方法
GB201501334D0 (en) * 2015-01-27 2015-03-11 Medtrade Products Ltd Composition for a wound dressing
GB201501333D0 (en) 2015-01-27 2015-03-11 Medtrade Products Ltd Composition for a wound dressing
CN105401232B (zh) * 2015-11-02 2017-09-29 浙江纺织服装科技有限公司 一种生物敷料用复合微纳米纤维膜的制备方法
CN105350105A (zh) * 2015-11-30 2016-02-24 莫程 一种苹果醋纤维及其制备方法
CN105839407B (zh) * 2016-04-19 2018-05-08 东南大学 一种医用高分子材料纳米纤维的表面生物功能化方法
US11013827B2 (en) 2016-04-30 2021-05-25 Bvw Holding Ag Microstructured haptotaxic implant
EP3448448B1 (en) * 2016-04-30 2020-11-11 BVW Holding AG Microstructured haptotaxic implant
CZ309165B6 (cs) * 2016-10-20 2022-04-06 Ústav Struktury A Mechaniky Hornin Av Čr, V. V. I. Příprava nanokompozitní vrstvy na bázi kolagenových nanovláken
CN108404213B (zh) * 2018-05-14 2023-05-09 上海交通大学医学院附属第九人民医院 一种利用三维打印和静电纺丝技术制备肌腱支架方法
CN111455496A (zh) * 2019-01-20 2020-07-28 泽塔纳米科技（苏州）有限公司 一种抗菌的可生物降解的纳米纤维及其制备方法
DE102019104561A1 (de) 2019-02-22 2020-08-27 Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. Verfahren zur Herstellung einer Kompositschicht, elektrochemische Einheit und Verwendung der Kompositschicht
TWI751943B (zh) * 2021-04-21 2022-01-01 明志科技大學 生物可降解材料及其製法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020090725A1 (en) * 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US20060204441A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Cell scaffold matrices with incorporated therapeutic agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043085A (en) 1998-08-27 2000-03-28 Research Development Foundation Ehrlichia canis 120-kDa immunodominant antigenic protein and gene
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
CZ20032421A3 (cs) 2003-09-08 2004-11-10 Technická univerzita v Liberci Způsob výroby nanovláken z polymerního roztoku elektrostatickým zvlákňováním a zařízení k provádění způsobu
ITRM20040539A1 (it) 2004-11-02 2005-02-02 Mavi Sud S R L Preparati a base di chitina o suoi derivati per uso cosmetico o medico.
KR100753116B1 (ko) 2004-12-22 2007-08-29 경북대학교 산학협력단 세포 배양용 나노섬유 지지체
US20090075354A1 (en) 2005-06-07 2009-03-19 The University Of Akron Nanofiber structures for supporting biological materials
GB0603122D0 (en) 2006-02-16 2006-03-29 Univ Bolton Higher Education C Improvements in and relating to composites
CZ304742B6 (cs) 2006-07-24 2014-09-17 Elmarco S.R.O. Sběrná elektroda zařízení pro výrobu nanovláken elektrostatickým zvlákňováním polymerních roztoků
CZ299549B6 (cs) 2006-09-04 2008-08-27 Elmarco, S. R. O. Rotacní zvláknovací elektroda
CN100535212C (zh) 2006-10-11 2009-09-02 东华大学 胶原蛋白和壳聚糖复合纳米纤维静电纺丝的制备方法
CZ2007485A3 (cs) 2007-07-17 2009-04-22 Elmarco, S. R. O. Zpusob zvláknování kapalné matrice, zarízení pro výrobu nanovláken elektrostatickým zvláknováním kapalné matrice a zvláknovací elektroda pro takové zarízení

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020090725A1 (en) * 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US20060204441A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Cell scaffold matrices with incorporated therapeutic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Bhattarai et al. "Electrospun Chitosan-Based Nanofibers and their Cellular Compatibility" BIOMATERIALS, vol. 26, no. 31 (November 2005), pages 6176-6184. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113445155A (zh) * 2021-07-22 2021-09-28 东北师范大学 一种壳聚糖基纳米纤维及其制备方法

Also Published As

Publication number Publication date
PH12010500803A1 (en) 2009-04-23
TW200925342A (en) 2009-06-16
BRPI0818424A2 (pt) 2015-04-22
CZ2007716A3 (cs) 2009-04-29
WO2009049565A3 (en) 2010-02-25
JP2011500980A (ja) 2011-01-06
AU2008314287A1 (en) 2009-04-23
CA2702368A1 (en) 2009-04-23
IL205093A0 (en) 2010-11-30
MX2010004085A (es) 2010-06-02
CN101903568A (zh) 2010-12-01
WO2009049565A2 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
US20100244331A1 (en) Method for Production of Nanofibres
Jayakumar et al. Novel chitin and chitosan nanofibers in biomedical applications
Schiffman et al. A review: electrospinning of biopolymer nanofibers and their applications
Naseri et al. Electrospun chitosan-based nanocomposite mats reinforced with chitin nanocrystals for wound dressing
US11801328B2 (en) Electrospun nanofibers and membrane
Sandri et al. Electrospinning technologies in wound dressing applications
KR101175625B1 (ko) 유착방지막용 나노섬유시트 및 그 제조방법
Tamilarasi et al. Advances in electrospun chitosan nanofiber biomaterials for biomedical applications
CN101230150B (zh) 纯海藻酸钠纳米纤维膜材料的制备方法
Mohiti-Asli et al. Nanofibrous smart bandages for wound care
WO2007112446A2 (en) Alginate-based nanofibers and related scaffolds
RU2487701C2 (ru) Раствор для получения материала на основе хитозана, способ получения гемостатического материала из этого раствора (варианты) и медицинское изделие с использованием волокон на основе хитозана
KR20150013281A (ko) 다당류 섬유의 제조 방법, 이를 포함하는 상처 피복재, 상처 피복재의 제조 방법, 및 다당류 섬유의 제조 장치
WO2018056937A2 (en) Nanofibrous adhesion barrier
Lu et al. Electrospinning of collagen and its derivatives for biomedical applications
Deshmukh et al. A review on biopolymer-derived electrospun nanofibers for biomedical and antiviral applications
Singh et al. Chitin, chitosan, and silk fibroin electrospun nanofibrous scaffolds: a prospective approach for regenerative medicine
JP4417909B2 (ja) エラスチン成形体およびその製造法
Poshina et al. Electrospinning of polysaccharides for tissue engineering applications
Jayakumar et al. Perspectives of chitin and chitosan nanofibrous scaffolds in tissue engineering
Bossard et al. Biomaterials from chitosan processed by electrospinning
Naghibzadeh Nanofibers for Skin Regeneration.
Thillaipandian et al. Biofunctional textile fibres and their applications
Valizadeh et al. Recent advances in electrospinning of some selected biopolymers
López-Córdoba et al. Cellulose-containing scaffolds fabricated by electrospinning: applications in tissue engineering and drug delivery

Legal Events

Date Code Title Description
AS Assignment

Owner name: ELMARCO S.R.O., CZECH REPUBLIC

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SVOBODOVA, JANA;REEL/FRAME:025024/0384

Effective date: 20100719

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION